Bal Pharma Ltd.

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

121.00

-1.95 (-1.59%)

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

NSE BSE

Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals

121.00

-1.95 (-1.59%)
15:15 Dec 26

Quality

77/100
High Financial Strength

Valuation

68/100
Affordable Valuation

Technical

53/100
Technically Neutral

Strength

Weakness

Opportunity

Threats

ROE %

ROA %

EPS

BVPS

Net Profit Margin

Income Statement Balance sheet Cash flow Ratio Shareholding

Quarterly Annual

Consolidated Standalone

	Mar 2021	Mar 2022	Mar 2023	Mar 2024	TTM 2024
Net Sales	250.53	281.21	304.22	339.22	324.34
Operating Expenses +	226.07	257.73	279.09	307.69	292.79
Raw Material	145.9	172.42	190.64	192.82	174.42
Increase Decrease in Cost	5.05	-4.89	-17.87	-1.06	2.26
Other Manufacturing Expense	0	0	0	0	0
Employee Cost	41.88	47.25	55.3	60.38	61.83
Miscellaneous Expenses	54.1	59.81	73.92	78.03	54.28
Operating Profit	24.46	23.48	25.13	31.53	31.55
Other Income	1.14	5.15	0.94	2.85	3.17
Depreciation	9.52	9.04	9.13	10.07	10.03
Interest	11.97	10.41	12.19	15.26	15.69
Profit before tax and exceptio..	4.1	9.18	4.75	9.05	9
Exceptional Items	0	0	0	0	0
PBT	4.1	9.18	4.75	9.05	9
Provision for Taxation	-0.61	3.48	2.13	1.6	1.32
Net Profit	4.71	5.7	2.62	7.45	7.68
NET Profit after MI	4.74	5.61	2.57	7.39	7.66
EPS	3.34	3.79	1.67	4.94	5.08
Operating Profit Margin (%)	9.76	8.35	8.26	9.29	9.73
Net Profit Margin (%)	1.89	2	0.84	2.18	2.36

ShareHolding

All Data in Percentage (%)

	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23
Promoter	50.90	51.20	51.20	51.20	51.60
FII	0.10	0.10	0.10	0.10	0.10
MF	0.00	0.00	0.00	0.00	0.00
Public	49.00	48.60	48.60	48.60	48.20
Others	0.00	0.10	0.10	0.10	0.10
Others	0.00	0.00	0.00	0.00	0.00